Effects of Montelukast on Early Life Wheezing

Trial Profile

Effects of Montelukast on Early Life Wheezing

Phase of Trial: Phase II/III

Latest Information Update: 16 Mar 2017

At a glance

  • Drugs Montelukast (Primary)
  • Indications Wheezing
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Dec 2016 Status changed from active, no longer recruiting to completed.
    • 02 Nov 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 20 Feb 2013 Planned end date changed from 1 Jun 2009 to 1 Sep 2020 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top